DOCS vs MRNA · P/E 21, rev $570.4M vs rev $1.94B
Doximity Inc (DOCS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DOCS and MRNA stock pages for the full models.
Not investment advice.